Breaking News, Promotions & Moves

Odyssey Therapeutics Taps Dennis Dean as EVP and Head of Non-Clinical Development

Dr. Dean will lead all preclinical research and development activities that support the progression of Odyssey’s drug candidates from discovery to clinical trials.

Author Image

By: Charlie Sternberg

Associate Editor

Dennis Dean, Ph.D.

Odyssey Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Dennis Dean, Ph.D., as Executive Vice President and Head of Non-Clinical Development. Dean will lead all preclinical research and development activities that support the progression of Odyssey’s drug candidates from discovery to clinical trials, including oversight of toxicology, drug metabolism and pharmacokinetics (DMPK), chemistry, manufacturing and controls (CMC), and program management. He will work c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters